Patent · US Active

Modified polypeptides for bispecific antibody scaffolds

US9527927B2 · kind B2 · utility

18Cited by

0References

11Claims

0Family size

Assignee

MedImmune Limited · US

Inventors

Partha S. Chowdhury · Gaithersburg, US
Vaheh Oganesyan · Gaithersburg, US
Yariv Mazor · Austin, US
Nazzareno Dimasi · Gaithersburg, US

Key dates

Filing date	Dec 18, 2012
Grant date	Dec 27, 2016
Priority date	—
Expiry date	Dec 18, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The technology relates in part to engineered antibodies. In particular, multispecific engineered antibodies. Such antibodies can be utilized for diagnostic and therapeutic applications in some aspects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.